We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Deltex Medical Group Plc | LSE:DEMG | London | Ordinary Share | GB0059337583 | ORD 0.01P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.005 | 3.85% | 0.135 | 0.13 | 0.14 | 0.135 | 0.13 | 0.13 | 130,555 | 09:18:03 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Electromedical Apparatus | 2.48M | -1.15M | -0.0006 | -2.17 | 2.4M |
TIDMDEMG
RNS Number : 1796H
Deltex Medical Group PLC
15 August 2016
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) --------------------------------------------------------------------------------------- 1. Identity of the issuer or Deltex Medical Group plc the underlying issuer of existing shares to which voting rights are attached: (ii) ----------------------------------------------------------- -------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): --------------------------------------------------------------------------------------- An acquisition or disposal of voting rights X ------------------------------------------------------------ ------------------------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached ------------------------------------------------------------ ------------------------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ------------------------------------------------------------ ------------------------- An event changing the breakdown of voting rights ------------------------------------------------------------ ------------------------- Other (please specify): ---------------------------------------------------------- ------------------------- 3. Full name of person(s) Andrew Muir subject to the notification obligation: (iii) ----------------------------------------------------------- -------------------------- 4. Full name of shareholder(s) (if different from 3.):(iv) ----------------------------------------------------------- -------------------------- 5. Date of the transaction 12 August 2016 and date on which the threshold is crossed or reached: (v) ----------------------------------------------------------- -------------------------- 6. Date on which issuer 15 August 2016 notified: ----------------------------------------------------------- -------------------------- 7. Threshold(s) that is/are crossed or reached: (vi, vii) 5% ----------------------------------------------------------- -------------------------- 8. Notified details: ---------------------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares (viii, ix) ---------------------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE -------------- ---------------------------------- ------------------------------------------------------------------ Number Number Number Number of % of voting of of of shares voting rights (x) Shares Voting rights Rights -------------- ---------------- ---------------- -------------- ----------------------- ------------------------- Direct Direct Indirect Direct Indirect (xi) (xii) -------------- ------------ ------------ -------------- --------- ------------ ------------ ----------- GB0059337583 13,649,471 13,649,471 14,449,471 14,449,471 5.07 ---------------- ---------------- -------------- --------- ------------ ------------ ----------- B: Qualifying Financial Instruments ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of financial Expiration Exercise/ Number of voting % of voting instrument date Conversion rights that rights (xiii) Period (xiv) may be acquired if the instrument is exercised/ converted. ------------------ -------------- -------------------------------- ------------------------- --------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of Exercise Expiration Exercise/ Number of voting % of voting financial price date Conversion rights instrument rights (xix, instrument (xvii) period refers to xx) (xviii) ---------------- -------------- -------------- ---------------- ------------------------- ----------------------- Nominal Delta ---------------- -------------- -------------- ---------------- ------------------------- ------------ --------- Total (A+B+C) ---------------------------------------------------------------------------------------------------------------------- Number of voting rights Percentage of voting rights ---------------------------------------------------- ---------------------------------------------------------------- 14,449,471 5.07 ---------------------------------------------------- ---------------------------------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) ---------------------------------------------------------------------------------------------- Proxy Voting: ---------------------------------------------------------------------------------------------- 10. Name of the proxy holder: ------------------------------------------------------------- ------------------------------- 11. Number of voting rights proxy holder will cease to hold: ------------------------------------------------------------- ------------------------------- 12. Date on which proxy holder will cease to hold voting rights: ------------------------------------------------------------- ------------------------------- 13. Additional information: ------------------------------------------------------------- ------------------------------- 14. Contact name: Jonathan D Shaw, Group Finance Director, Deltex Medical Group plc ------------------------------------------------------------- ------------------------------- 15. Contact telephone number: 01243 774837 ------------------------------------------------------------- -------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLEAEPSFELKEFF
(END) Dow Jones Newswires
August 15, 2016 06:10 ET (10:10 GMT)
1 Year Deltex Medical Chart |
1 Month Deltex Medical Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions